Who owns SciClone Pharmaceuticals?

Key details on SciClone Pharmaceuticals (Ticker: SCLN)

Who owns SciClone Pharmaceuticals?

Is SCLN a good stock to own? Find out who bought SciClone Pharmaceuticals, who sold SciClone Pharmaceuticals (SCLN) stock, and who holds a large position in SciClone Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Franklin Resources 3.52M $17.73M Dec. 31, 2013
BlackRock Institutional Trust Company, N.A. 2.97M $14.97M Dec. 31, 2013
LSV Asset Management 2.63M $13.26M Dec. 31, 2013
DIMENSIONAL FUND ADVISORS 2.16M $10.89M Dec. 31, 2013
BlackRock Fund Advisors 2.11M $10.61M Dec. 31, 2013
Schroder Investment Management 2.05M $10.15M June 30, 2013
Nantahala Capital Management 1.54M $7.74M Dec. 31, 2013
Apex Capital 1.45M $8.07M Sept. 30, 2012
Vanguard 1.39M $7.00M Dec. 31, 2013
Ayer Capital Management 1.25M $8.76M June 30, 2012
STATE STREET CORPORATION 1.08M $4.65M Dec. 31, 2013
FMR 1.02M $6.45M March 31, 2012
OppenheimerFunds 1.01M $5.63M Sept. 30, 2012
WALL STREET ASSOCIATES 1.00M $6.32M March 31, 2012
Acadian Asset Management 995106 $4.53M March 31, 2014
ARONSON JOHNSON ORTIZ 956000 $4.85M Sept. 30, 2013
NORTHERN TRUST 790466 $3.98M Dec. 31, 2013
Batterymarch Financial Management 777507 $3.92M Dec. 31, 2013
Austin W. Marxe and David M. Greenhouse 750000 $4.16M Sept. 30, 2012
Sparta Asset Management 695209 $4.39M March 31, 2012
GRANAHAN INVESTMENT MANAGEMENT INC/MA 636824 $4.46M June 30, 2012
BlackRock Advisors 628971 $3.17M Dec. 31, 2013
Inves 618194 $4.33M June 30, 2012
Technical Financial Services 570502 $2.83M June 30, 2013
Renaissance Technologies 506100 $2.57M Sept. 30, 2013
JPMORGAN CHASE & CO 437723 $2.21M Dec. 31, 2013
FIL 427819 $1.97M March 31, 2013
Millennium Management 409768 $2.07M Dec. 31, 2013
Charles Schwab Investment Management 386685 $1.79M March 31, 2013
ALGERT COLDIRON INVESTORS 379614 $1.64M Dec. 31, 2012
AQR Capital Management 364380 $1.85M Sept. 30, 2013
TIAA-CREF Investment Management 344771 $1.75M Sept. 30, 2013
Oxford Asset Management 342136 $1.73M Sept. 30, 2013

Who sold SciClone Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
DuPont Capital Management Corporation March 31, 2012 529299 $3.34B
GOLDMAN SACHS Sept. 30, 2011 383990 $1.46M
Johnson Investment Counsel June 30, 2011 773700 $2.56M
Two Sigma Investments June 30, 2011 358997 $2.17M
Eudaimonia Asset Management June 30, 2011 332362 $2.01M
MCKINLEY CAPITAL MANAGEMENT March 31, 2011 420023 $1.70M
ZPR Investment Management Dec. 31, 2010 658390 $2.75M